| 15th Mar 2021 5:22 pm |
RNS |
Issue of Equity |
| 9th Mar 2021 7:00 am |
RNS |
Diagnostic Licensing Deal with Biokit |
| 8th Mar 2021 7:00 am |
RNS |
Rapid Antigen Test Detects SARS-CoV-2 Variants |
| 3rd Mar 2021 5:14 pm |
RNS |
Electronic Communications with Shareholders |
| 24th Feb 2021 7:00 am |
RNS |
Business Update |
| 22nd Feb 2021 7:00 am |
RNS |
Re: Press Speculation |
| 18th Feb 2021 7:00 am |
RNS |
Phase I CTA for AVA6000 Approved by MHRA |
| 16th Feb 2021 9:05 am |
RNS |
Second Price Monitoring Extn |
| 16th Feb 2021 9:00 am |
RNS |
Price Monitoring Extension |
| 16th Feb 2021 7:00 am |
RNS |
Results of Initial Evaluation of SARS-CoV-2 LFT |
| 8th Feb 2021 7:00 am |
RNS |
Commercial Partnership with Mologic |
| 2nd Feb 2021 8:30 am |
RNS |
Issue of Equity |
| 1st Feb 2021 7:00 am |
RNS |
AffyXell $7.3 Million Series A Financing |
| 29th Jan 2021 11:00 am |
RNS |
Issue of Equity |
| 28th Jan 2021 7:00 am |
RNS |
Collaboration Agreement with Bruker |
| 7th Jan 2021 7:00 am |
RNS |
License Agreement with POINT Biopharma Inc. |
| 5th Jan 2021 11:05 am |
RNS |
Second Price Monitoring Extn |
| 5th Jan 2021 11:00 am |
RNS |
Price Monitoring Extension |
| 23rd Dec 2020 7:00 am |
RNS |
Submission of CTA for AVA6000 Pro-doxorubixin |
| 21st Dec 2020 7:00 am |
RNS |
License Agreement with Astrea Bioseparations |
| 23rd Nov 2020 9:05 am |
RNS |
Second Price Monitoring Extn |
| 23rd Nov 2020 9:00 am |
RNS |
Price Monitoring Extension |
| 23rd Nov 2020 7:00 am |
RNS |
SARS-CoV-2 Rapid Antigen Test Update |
| 18th Nov 2020 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 18th Nov 2020 4:36 pm |
RNS |
Price Monitoring Extension |
| 13th Nov 2020 2:15 pm |
RNS |
Issue of Equity |
| 10th Nov 2020 11:06 am |
RNS |
Second Price Monitoring Extn |
| 10th Nov 2020 11:00 am |
RNS |
Price Monitoring Extension |
| 9th Nov 2020 2:06 pm |
RNS |
Second Price Monitoring Extn |
| 9th Nov 2020 2:01 pm |
RNS |
Price Monitoring Extension |
| 22nd Oct 2020 1:50 pm |
RNS |
Director/PDMR Shareholding |
| 8th Oct 2020 9:00 am |
RNS |
Issue of Equity |
| 30th Sep 2020 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 30th Sep 2020 2:00 pm |
RNS |
Price Monitoring Extension |
| 30th Sep 2020 10:35 am |
RNS |
Launch of SARS-CoV-2 BAMS Research Test |
| 29th Sep 2020 7:00 am |
RNS |
Appointment of Joint Broker |
| 28th Sep 2020 9:00 am |
RNS |
Price Monitoring Extension |
| 28th Sep 2020 7:00 am |
RNS |
Interim Results for the Period Ended 30 June 2020 |
| 24th Sep 2020 7:00 am |
RNS |
Update on Integumen Collaboration |
| 14th Sep 2020 7:00 am |
RNS |
Notice of Results and Investor Presentation |
